Drug Trial News

RSS

Contrary to popular belief, rural physician incomes on par with urban physicians

While lower incomes are an oft-cited obstacle to recruiting physicians to practice in rural America, average physician incomes in rural and urban areas do not differ significantly, according to a national study released today by the Center for Studying Health System Change (HSC).

27 Jan 2005

Doctors under pressure to compromise good health care for athletes

Doctors are repeatedly coming under pressure to compromise principles of good health care when treating athletes, reveals a small preliminary study in the Journal of Medical Ethics.

26 Jan 2005

Young, male, and infected - the forgotten victims of Chlamydia

While young women are being targeted in the bid to curb the spread of Chlamydia in primary care, young men are all too frequently being ignored, suggests a small study of practice nurses in Sexually Transmitted Infections.

26 Jan 2005

US rates of early death and disability from sexual behaviour triple those of other wealthy nations

The rates of premature death and disability attributable to sexual behaviour in the United States are triple those of other wealthy nations, suggests research in Sexually Transmitted Infections.

26 Jan 2005

Trial of Etanercept for Wegners's disease shows no benefit against the autoimmune condition

A Johns Hopkins-led study designed to evaluate the ability of etanercept to maintain disease remissions in a serious autoimmune disorder has failed to show any benefit. Etanercept, also called Enbrel, is a common treatment for rheumatoid arthritis and other types of joint inflammation.

26 Jan 2005

Study explains reasons behind recent Medicaid spending growth

Medicaid spending increased to $276 billion by fiscal year (FY)2003, up one-third from FY2000, according to a new web-exclusive article released today by the peer-reviewed journal Health Affairs and commissioned by the Kaiser Commission on Medicaid and the Uninsured.

26 Jan 2005

Increasing trend in society to be more open about the use of sperm donors

Two studies to be published tomorrow (Thursday 27 January) in Europe's leading reproductive medicine journal, Human Reproduction provide a generally optimistic picture about attitudes towards the increasing trend in society to be more open about the use of sperm donors.

26 Jan 2005

Exposure to infant siblings decreases multiple sclerosis risk

Adults who report having had higher exposure to infant siblings during their first 6 years of life have a reduced risk of multiple sclerosis (MS), according to a study in the January 26 issue of JAMA.

26 Jan 2005

Obesity and weight gain are associated with increased risk for developing kidney stones

Kidney stones are a major cause of illness, according to background information in the article. The lifetime prevalence of kidney stones is approximately 10 percent in men and 5 percent in women, and more than $2 billion is spent on treatment each year.

26 Jan 2005

Drug reviparin reduces the risk of death after heart attack

The drug reviparin (a low molecular weight heparin anticoagulant), when administered to patients with a heart attack, is effective in reducing the risk of death and the risk of a subsequent heart attack, according to a study in the January 26 issue of JAMA.

26 Jan 2005

New method of delivery of gene therapy may lead to safer treatment for cancer

The Lankenau Institute for Medical Research (LIMR) announced that in collaboration with the Massachusetts Institute of Technology (MIT) they have performed preclinical proof-of- principle studies showing how nanotechnology can be used to enhance gene therapy for cancer.

25 Jan 2005

Whole-body computed tomography (CT) is not a cost-effective screening method

The use of whole-body CT as a screening tool for cancer and other diseases is the focus of an ongoing debate. Proponents of whole-body CT emphasize the potential benefit of early detection of disease, but others caution that the costs, false-positive findings and unnecessary radiation might render the procedure more harmful than beneficial.

25 Jan 2005

Blood clots in the lungs could be prevented with computed tomography (CT) scans of the legs

Researchers found that indirect CT venography (CTV) could identify blood clots in the legs that have the potential to break free, travel to the lung and block an artery--a life-threatening condition known as pulmonary embolism.

25 Jan 2005

Sociologists create a love map for an entire high school

For the first time, sociologists have mapped the romantic and sexual relationships of an entire high school over 18 months, providing evidence that these adolescent networks may be structured differently than researchers previously thought.

25 Jan 2005

Younr black people experience the most pain

Adults under the age of 50 who have chronic pain may be less able to cope with their condition and more prone to associated depression than their elders, a new study suggests.

25 Jan 2005

Vioxx could have caused 140000 excess cases of coronary heart disease in the USA since 1999

The arthritis drug Vioxx could have caused an estimated 88 000–140 000 excess cases of serious coronary heart disease in the USA since its launch in 1999, concludes a study published online by The Lancet.

24 Jan 2005

Dietary fat quality may be more important than fat quantity in reducing risk of cardiovascular deaths in middle-aged men

The type of dietary fats consumed by middle-aged men, especially polyunsaturated fats and linoleic acids, may be more important than total fat intake in reducing the risk of cardiovascular deaths, according to a study in the January 24 issue of Archives of Internal Medicine.

24 Jan 2005

Warfarin combined with NSAIDs or COX-2 inhibitors increased risk of upper gastrointentinal hemorrhage

Patients taking warfarin at the same time as selective COX-2 inhibitors or nonselective NSAIDs have an increased risk of hospitalization for upper gastrointestinal (GI) hemorrhage, according to Canadian researchers analyzing health care databases.

24 Jan 2005

Study of patients on COX-2 inhibitors does not show increased cardiovascular risk

An observational study of 6,250 patients enrolled in the Maryland Medicaid program found that COX-2 inhibitors did not increase the risk for cardiovascular events over nonnaproxen NSAIDs in a high-risk population.

24 Jan 2005

More studies on risks and benefits of COX-2 inhibitors

A group of studies published in the January 24 issue of Archives of Internal Medicine add to the growing body of medical literature about the cardiovascular risks that may be associated with the class of pain-relieving drugs known as COX-2 inhibitors.

24 Jan 2005

Drug Trial News

Contrary to popular belief, rural physician incomes on par with urban physicians

Doctors under pressure to compromise good health care for athletes

Young, male, and infected - the forgotten victims of Chlamydia

US rates of early death and disability from sexual behaviour triple those of other wealthy nations

Trial of Etanercept for Wegners's disease shows no benefit against the autoimmune condition

Study explains reasons behind recent Medicaid spending growth

Increasing trend in society to be more open about the use of sperm donors

Exposure to infant siblings decreases multiple sclerosis risk

Obesity and weight gain are associated with increased risk for developing kidney stones

Drug reviparin reduces the risk of death after heart attack

New method of delivery of gene therapy may lead to safer treatment for cancer

Whole-body computed tomography (CT) is not a cost-effective screening method

Blood clots in the lungs could be prevented with computed tomography (CT) scans of the legs

Sociologists create a love map for an entire high school

Younr black people experience the most pain

Vioxx could have caused 140000 excess cases of coronary heart disease in the USA since 1999

Dietary fat quality may be more important than fat quantity in reducing risk of cardiovascular deaths in middle-aged men

Warfarin combined with NSAIDs or COX-2 inhibitors increased risk of upper gastrointentinal hemorrhage

Study of patients on COX-2 inhibitors does not show increased cardiovascular risk

More studies on risks and benefits of COX-2 inhibitors

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Latest News